Application Stage

  • Full applications will be accepted by invitation only after review of Letters of Intent submitted during the 2019 submission period.
  • Applications must be submitted through The Mark Foundation’s online portal. No paper submissions will be accepted.
  • Applicants must be available to travel to New York City for final-round in-person interviews the week of October 14, 2019.
  • Award Finalists will be required to submit the following additional information:

o Biohazard Statement
o If the proposed research involves the use of human subjects, applicant must provide an explanation of IRB Approval & Human Subject Assurance Number.
o If the proposed research uses vertebrate animals, applicant must provide IACUC & Animal Welfare Assurance Number and documentation.

Sample Application

Grant applications are accepted by invitation only. All applications must be submitted through The Mark Foundation’s online portal no later than 5 PM Eastern Time on June 28, 2019. No paper submissions will be accepted. The following sections are to be included in the Grant Application:

  • Project Title
  • Project Summary/Abstract (≤ 350 words)
  • Project Description (≤ 2500 words [approximately five pages]; maximum four figure uploads)

o Statement of unmet need
o Relevant background and preliminary data, relevant hypotheses
o Specific aims
o Experimental plan with potential pitfalls and alternative approaches.

  • Budget Justification: Provide a short paragraph on how this award will be used to extend your research in new directions. Please do not provide a detailed budget or specific spending plan.
  • Letters of support from key collaborators (optional).

Proposals should include a statement of impact describing how the proposed work addresses an important unmet need and advances knowledge in the field of cancer research. This statement should also include commentary on the impact of The Mark Foundation’s funding in propelling research that would otherwise not be pursued or pursued on very prolonged timelines.